Question 1

Has Lawrence Leventhal received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,139,585 in general payments to Lawrence Leventhal across 1,496 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Lawrence Leventhal did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Lawrence Leventhal come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Amgen(2 entities)	435	$334,025
Lilly USA, LLC	399	$317,272
AbbVie	310	$224,206
Novartis	102	$72,556
Bristol Myers Squibb	58	$61,797
UCB, Inc.	53	$40,051
Janssen Research & Development, LLC	13	$35,490
Sanofi	33	$28,993
E.r. Squibb & Sons, L.L.C.	29	$14,474
Pfizer	19	$5,965
Regeneron Healthcare Solutions, Inc.	9	$3,862
Mallinckrodt Hospital Products Inc.	5	$247
Mallinckrodt Enterprises LLC	6	$158
GSK	6	$150
Pacira Therapeutics, Inc.	5	$89
Sobi, Inc	3	$76
Genentech USA, Inc.	3	$56
Radius Health, Inc.	2	$41
Hikma Pharmaceuticals USA	2	$26
Medexus Pharma, Inc.	2	$24
AstraZeneca	1	$15
Johnson & Johnson	1	$12

Lawrence Leventhal

Payments from drug & device makers

Who reported the general payments

How this compares

Other rheumatology in Huntingdon Valley